CLO25-076: CD13 as a Potential Membrane Marker in PSMA-Negative Prostate Cancer and First-in-Human Study of [18F]AlF-CD13-L1 PET/CT Imaging
- Wei Tang 1, Ming Zhou 2, Chenxi Lu 2, Lin Qi 1, Ye Zhang 3, Yongxiang Tang 2, Xiaomei Gao 4, Shuo Hu 4,5, Yi Cai 1
- 11Department of Urology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
- 22Department of Nuclear Medicine, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
- 33Department of Oncology, NHC Key Laboratory of Cancer Proteomics, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
- 44Department of Pathology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
- 55Key Laboratory of Biological Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha, China.
- 01Department of Urology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.